Home Health News FDA Reverses Stance on Leucovorin for Autism By News Health 1 month Ago Share on FacebookShare on Twitter (MedPage Today) — The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday. Leucovorin is… Source link : https://www.medpagetoday.com/neurology/autism/120245 Author : Publish date : 2026-03-10 21:00:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Two Resuscitation Fluids Led to Similar Outcomes in Kids With Septic Shock By News Health April 24, 2026 AOC vs RFK Jr. Memes; Are Doctors OK? Communicating With Gen Z Patients By News Health April 23, 2026 'Ozempic Personality': Is Emotional Flattening Another Side Effect of GLP-1s? By News Health April 23, 2026 Omalizumab Plus Immunotherapy May Ease Allergic Asthma By News Health April 23, 2026 First Gene Therapy Approved for Hearing Loss By News Health April 23, 2026 Think Heart Attacks Cause Most Sudden Cardiac Deaths? Think Again, Study Says By News Health April 23, 2026